You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neutralizing Monoclonal Antibody

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis b Virus Trial in New York (HepB mAb19, Sterile Saline)

Not yet recruiting
  • Hepatitis b Virus
  • HepB mAb19
  • Sterile Saline
  • New York, New York
  • +1 more
May 12, 2023

SARS-CoV-2 Infection Trial in Cologne (DZIF-10c, Placebo)

Completed
  • SARS-CoV-2 Infection
  • DZIF-10c
  • Placebo
  • Cologne, NRW, Germany
    University Hospital Cologne
Aug 22, 2021

SARS-CoV-2 Infection Trial in Germany (DZIF-10c, Placebo)

Completed
  • SARS-CoV-2 Infection
  • DZIF-10c
  • Placebo
  • Gießen, Hesse, Germany
  • +5 more
Oct 23, 2021

Human Immunodeficiency Virus Trial in New York, Philadelphia (3BNC117-LS, 10-1074-LS, N803)

Not yet recruiting
  • Human Immunodeficiency Virus
  • New York, New York
  • +2 more
Jul 12, 2022

HIV Trial in Worldwide (VRC01, Placebo for VRC01)

Completed
Has Results
  • HIV Infections
  • VRC01
  • Placebo for VRC01
  • Gaborone, South-East District, Botswana
  • +20 more
Feb 8, 2022

West Nile Virus Trial in Baltimore (MGAWN1, Placebo)

Completed
  • West Nile Virus
  • Baltimore, Maryland
    PAREXEL Phase 1 Unit
Feb 4, 2022

HIV Trial in Bangkok (VRC01, Placebo for VRC01)

Completed
Has Results
  • HIV Infections
  • VRC01
  • Placebo for VRC01
  • Bangkok, Thailand
    SEARCH Thai Red Cross AIDS Research Centre Non-Network CRS
Oct 29, 2021

HIV Trial in Birmingham, Philadelphia (VRC01)

Completed
Has Results
  • HIV Infections
  • VRC01
  • Birmingham, Alabama
  • +1 more
Oct 15, 2021

SARS-CoV-2, Prevention Trial in Chongqing (MY-586 SARS-CoV-2 Neutralizing Antibody nasal spray, Placebo Comparator: MY-586

Recruiting
  • SARS-CoV-2
  • Prevention
  • MY-586 SARS-CoV-2 Neutralizing Antibody nasal spray
  • Placebo Comparator: MY-586 SARS-CoV-2 Neutralization Antibody nasal excipient
  • Chongqing, Chongqing, China
    The Second Affiliated Hospital of Chongqing Medical University
Aug 2, 2023

HIV Trial in Worldwide (VRC01, Placebo for VRC01)

Completed
Has Results
  • HIV Infections
  • VRC01
  • Placebo for VRC01
  • Birmingham, Alabama
  • +25 more
Feb 8, 2022

HIV Trial in Worldwide (VRC01, Placebo for VRC01, Antiretroviral therapy (ART) (regimen will vary within countries and by

Completed
  • HIV Infections
  • VRC01
  • +2 more
  • Kericho, Kenya
  • +4 more
Nov 23, 2021

COVID-19 Trial in Beijing (SA55 nasal spray)

Recruiting
  • COVID-19
  • SA55 nasal spray
  • Beijing, Chaoyang, China
    Beijing Ditan Hospital Capital Medical University
Sep 15, 2023

COVID-19, SARS-CoV-2 Trial in China (JS016)

Recruiting
  • COVID-19
  • SARS-CoV-2
  • Beijing, Beijing, China
  • +3 more
Oct 13, 2021

NSCLC Stage IV Trial (HLX26, Serplulimab, Pemetrexed)

Not yet recruiting
  • NSCLC Stage IV
  • (no location specified)
Mar 15, 2023

Solid Tumors Trial in Seoul (YYB101)

Completed
  • Solid Tumors
  • Seoul, Korea, Republic of
    Samsung Medical Center
May 12, 2021

RSV Infection Trial in Orlando (RSM01, Placebo)

Completed
  • RSV Infection
  • Orlando, Florida
    PPD Phase I Clinic - Orlando
Dec 14, 2022

Lymphoma, Non-Hodgkin, Lymphoma, T-Cell Trial in Najing (Recombinant Humanized Anti-CD52 Monoclonal Antibody Injection)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Lymphoma, T-Cell
  • Recombinant Humanized Anti-CD52 Monoclonal Antibody Injection
  • Najing, Jiangsu, China
    Jiangsu Provincial People's Hospital
Sep 26, 2022

HIV Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (VRC-HIVMAB0115-00-AB)

Recruiting
  • HIV
  • VRC-HIVMAB0115-00-AB
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Rabies Virus Infection Trial in Kunming (Natural full human mAb CBB 1 injection, Rabies Human Immunoglobulin (HRIG), Natural

Not yet recruiting
  • Rabies Virus Infection
  • Natural full human monoclonal antibody CBB 1 injection
  • +3 more
  • Kunming, Yunnan, China
    The First Affiliated Hospital of Yunnan University of Traditiona
Apr 14, 2023

SARS-CoV-2, Prevention Trial in Chongqing (A8G6 SARS-CoV-2 Neutralization Antibody combination nasal spray, A8G6 SARS-CoV-2

Recruiting
  • SARS-CoV-2
  • Prevention
  • A8G6 SARS-CoV-2 Neutralization Antibody combination nasal spray
  • A8G6 SARS-CoV-2 Neutralization Antibody nasal excipient
  • Chongqing, Chongqing, China
    The Second Affiliated Hospital of Chongqing Medical University
Nov 9, 2023

AAV9 Neutralizing Antibody Seroconversion in Household Contacts.

Recruiting
  • Household Contacts
  • Blood Draw
  • Baltimore, Maryland
    Kennedy Krieger Institute
Oct 4, 2022

Healthy Trial in Qingdao (VDJ001, Placebo)

Completed
  • Healthy
  • Qingdao, Shandong, China
    the Affliated Hospital of Qingdao University
Aug 30, 2023

TURN-COVID Biobank: The Dutch Cohort Study for Evaluation of Use

Recruiting
  • COVID-19
  • casirivimab with imdevimab
  • +2 more
  • Amsterdam, Noord Holland, Netherlands
  • +3 more
Jan 13, 2022

Bevacizumab Combined With PD-1 Monoclonal Antibody in

Not yet recruiting
  • Colorectal Cancer
  • Bevacizumab Combined With PD-1 Monoclonal Antibody
  • (no location specified)
Nov 8, 2023

Antibody-mediated Rejection, Kidney Tranplant Trial in Hangzhou (Daratumumab)

Not yet recruiting
  • Antibody-mediated Rejection
  • Kidney Tranplant
  • Hangzhou, Zhejiang, China
    79# Qingchun Road
Jun 21, 2023